Yanjie Hao
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research 20
- Rheumatoid Arthritis Research and Therapies 7
-
- Systemic Sclerosis and Related Diseases 8
-
- Atherosclerosis and Cardiovascular Diseases 6
-
- Pulmonary Hypertension Research and Treatments 5
- Dermatology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Connective Tissue Growth Factor Research 6
-
- Chronic Lymphocytic Leukemia Research 3
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yanjie Hao
41 papers receiving 827 citations
Peers
Comparison fields: 5 of 60
- Rheumatology 326
- Pathology and Forensic Medicine 303
- Immunology 213
- Pulmonary and Respiratory Medicine 307
- Dermatology 59
Countries citing papers authored by Yanjie Hao
This map shows the geographic impact of Yanjie Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjie Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjie Hao more than expected).
Fields of papers citing papers by Yanjie Hao
This network shows the impact of papers produced by Yanjie Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjie Hao. The network helps show where Yanjie Hao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanjie Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 23 | |
| 10 | 2021 | 39 | |
| 11 | 2020 | 15 | |
| 12 | 2019 | 1 | |
| 13 | Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016. | 2018 | 14 |
| 14 | 2017 | 10 | |
| 15 | 2016 | 138 | |
| 16 | [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment]. | 2015 | 3 |
| 17 | 2015 | 88 | |
| 18 | 2014 | 5 | |
| 19 | 2011 | 4 | |
| 20 | 2008 | 12 |
About Yanjie Hao
Yanjie Hao is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine, having authored 47 papers that have together received 837 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (20 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Systemic Sclerosis and Related Diseases (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Connective Tissue Growth Factor Research (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Rheumatology (326 citations), Pathology and Forensic Medicine (303 citations) and Immunology (213 citations). Yanjie Hao has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Zhuoli Zhang, Yong Fan, Guangtao Li, Yan Geng, Hong Huang, Lanlan Ji, Mandana Nikpour, Wenhui Xie, Dai Gao and Yu Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.